Maturation of Asn-linked oligosaccharides in the eukaryotic secretory pathway requires the trimming of nascent glycan chains to remove all glucose and several mannose residues before extension into complex-type structures on the cell surface and secreted glycoproteins. Multiple glycoside hydrolase family 47 (GH47) α-mannosidases, including endoplasmic reticulum (ER) α-mannosidase I (ERManI) and Golgi α-mannosidase IA (GMIA), are responsible for cleavage of terminal α1,2-linked mannose residues to produce uniquely trimmed oligomannose isomers that are necessary for ER glycoprotein quality control and glycan maturation. ERManI and GMIA have similar catalytic domain structures, but each enzyme cleaves distinct residues from tribranched oligomannose glycan substrates. The structural basis for branch-specific cleavage by ERManI and GMIA was explored by replacing an essential enzyme-bound Ca 2+ ion with a lanthanum (La
Maturation of Asn-linked oligosaccharides in the eukaryotic secretory pathway requires the trimming of nascent glycan chains to remove all glucose and several mannose residues before extension into complex-type structures on the cell surface and secreted glycoproteins. Multiple glycoside hydrolase family 47 (GH47) α-mannosidases, including endoplasmic reticulum (ER) α-mannosidase I (ERManI) and Golgi α-mannosidase IA (GMIA), are responsible for cleavage of terminal α1,2-linked mannose residues to produce uniquely trimmed oligomannose isomers that are necessary for ER glycoprotein quality control and glycan maturation. ERManI and GMIA have similar catalytic domain structures, but each enzyme cleaves distinct residues from tribranched oligomannose glycan substrates. The structural basis for branch-specific cleavage by ERManI and GMIA was explored by replacing an essential enzyme-bound Ca 2+ ion with a lanthanum (La 3+ ) ion. This ion swap led to enzyme inactivation while retaining high-affinity substrate interactions. Cocrystallization of La 3+ -bound enzymes with Man 9 GlcNAc 2 substrate analogs revealed enzyme-substrate complexes with distinct modes of glycan branch insertion into the respective enzyme active-site clefts. Both enzymes had glycan interactions that extended across the entire glycan structure, but each enzyme engaged a different glycan branch and used different sets of glycan interactions. Additional mutagenesis and time-course studies of glycan cleavage probed the structural basis of enzyme specificity. The results provide insights into the enzyme catalytic mechanisms and reveal structural snapshots of the sequential glycan cleavage events. The data also indicate that full steric access to glycan substrates determines the efficiency of mannose-trimming reactions that control the conversion to complex-type structures in mammalian cells.
Asn-linked glycan processing | α-mannosidase | glycosidase mechanism | glycoside hydrolase | bioinorganic chemistry M ammalian Asn-linked glycoproteins are initially synthesized by cotranslational transfer of a Glc 3 Man 9 GlcNAc 2 glycan precursor to nascent polypeptide chains on the luminal face of the endoplasmic reticulum (ER) (1) . During transit through the secretory pathway, all three glucose residues and six of nine mannose residues are trimmed, and the structures are extended further by Golgi glycosyltransferases to generate the diverse collection of complex-type glycans found on cell-surface and secreted glycoproteins (2) . The transiently formed glycanprocessing intermediates resulting from glucose and mannose cleavage also play critical roles in the early secretory pathway, including acting as ligands for ER chaperones, signals for ER quality control and ER-associated degradation (ERAD), and targeting signals during intracellular transport (3) (4) (5) (6) .
Key steps in the generation of the trimmed oligomannose glycans are catalyzed by a collection of α-mannosidases, termed "class 1" or "Carbohydrate Active Enzymes Database (CAZy) glycoside hydrolase family 47" (GH47) α-mannosidases (7, 8) , that selectively cleave α1,2-mannose residues from the Man 9 GlcNAc 2 precursor. In mammals, there are seven GH47 members (6) , including ER α1,2-mannosidase I (ERManI), three Golgi α1,2-mannosidases (GMIA, GMIB, and GMIC), which play important roles in N-glycan trimming in the ER and Golgi complex, and three ER degradation-enhancing α-mannosidase-like (EDEM) proteins (EDEM1, EDEM2, and EDEM3) that play roles in ERAD (3, 6) . In classical models for mammalian N-glycan maturation, Man 9 GlcNAc 2 structures are acted upon first by ERManI to cleave a single α1,2-mannose residue (M10) from the glycan B branch to generate a Man 8 GlcNAc 2 B isomer (Man8B) ( Fig. 1 ) (6, 9, 10) . This cleavage has been proposed to contribute to the mannose-timer mechanism for ER quality control and ERAD (1, 3, 5) . Following completion of protein folding and release from ER chaperones, N-glycoproteins with Man8B isomer glycans are transported to the Golgi complex where the remaining three α1,2-mannosyl residues are cleaved by GMIA, GMIB, or GMIC to generate Man 5 GlcNAc 2 ( Fig. 1C ) (11) (12) (13) . In vitro, ERManI and the Golgi α-mannosidases exhibit complementary and nonoverlapping specificities for cleavage of Man 9 GlcNAc 2 substrates. ERManI rapidly cleaves the single M10 (branch B) residue (9, 14) but cleaves the remaining mannose residues on other branches with greatly reduced efficiency (Fig. 1D ). In contrast,
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GMIA preferentially cleaves residue M11 to generate the Man8A isomer (90%) with a minor cleavage of residue M9 (10% Man8C) followed by the ordered and sequential cleavage of residues M9 and M8 (branches C and A) to generate Man 6 GlcNAc 2 ( Fig. 1E ) (15) . Residue M10 (branch B), the preferred residue for cleavage by ERManI, is poorly hydrolyzed by GMIA. Thus, both in vivo and in vitro studies of ERManI and GMIA indicate that the two enzymes cleave distinct subsets of terminal α1,2-linked mannose residues during glycan maturation in the secretory pathway.
In addition to studies on glycan cleavage, insights into substrate recognition and cleavage by GH47 α-mannosidases also have come from crystal structures of their respective catalytic domains in the absence and presence of various inhibitors and substrate analogs. The enzyme catalytic domains are comprised of a conserved (αα) 7 barrel structure with a β-hairpin plugging one end of the barrel; the other end is composed of a broad cleft that leads to the active site in the barrel core (10, 16) . A Ca 2+ ion is bound at the apex of the β-hairpin through direct coordination to eight oxygen atoms: two from carbonyl and γ oxygen atoms of a Thr residue and six from water molecules. Substrate interactions displace two of the water molecules through coordination with the C2 and C3 hydroxyls of the terminal α1,2-mannose residue within the catalytic −1 subsite (where bond cleavage occurs between the terminal catalytic −1 subsite and the subterminal +1 subsites) (Fig. S1B) . Previous studies characterized interactions with glycone-mimicking inhibitors within the −1 subsite (14, (16) (17) (18) (19) and a thiodisaccharide substrate analog that bridged the −1 and the adjoining +1 subsites (14, 19) through a highly conserved collection of hydrophobic and H-bonding interactions as well as direct coordination with the Ca 2+ ion. In contrast to the highly conserved −1 and +1 subsites, the topologies of the broad clefts (≥+1 subsites) leading to the active-site cores are distinct among the GH47 family members (10, (16) (17) (18) (19) (20) ; these distinct topologies have been proposed to account for the differences in branch specificities (20) . For example, protein-glycan complexes were obtained for both mouse GMIA (20) and the yeast ERManI (10) , in which the equivalent of Man 5 GlcNAc 2 enzymatic products occupied the ≥+1 subsites as ligands, but the −1 glycone subsites remained unoccupied. The orientations of the resulting glycans were distinct, and different branch termini were docked in the respective active-site clefts. However, these structures did not reveal interactions with the intact Man 9 GlcNAc 2 substrate or the determinants of initial glycan branch specificity.
A challenge for obtaining structural insights into GH47 α-mannosidase glycan cleavage intermediates has been the progressive digestion of glycan substrates by even partially inactivated mutant enzymes (21) . As an alternative approach for enzyme inactivation, we examined the role of the enzyme-bound Ca 2+ ion in catalysis. The role of ion coordination was probed by determining the structure of a mutant form of ERManI (T688A), which reduced the Ca 2+ ion coordination number and compromised catalysis while partially enhancing substrate-binding affinity. We further tested replacement of the Ca 2+ ion with other ions that could potentially eliminate enzymatic activity but maintain substrate-binding affinity. These studies revealed that exchanging the enzyme-bound Ca 2+ ion with a lanthanum (La 3+ ) ion resulted in complete enzyme inactivation while enhancing substrate-binding affinity. Cocrystallization of La
3+
-inactivated GMIA and ERManI with natural Man 9 GlcNAc 2 substrate analogs led to the formation of uncleaved enzyme-glycan complexes and provided detailed insights into initial enzyme-substrate interactions. Binding-cleft residues were probed by mutagenesis, time-course studies on the kinetics of glycan cleavage, and binding-affinity studies. These data demonstrated that the enzyme-glycan complexes reflected substrate-bound Michaelis complexes and provided insights into both the catalytic mechanism and mapping of the molecular determinants for branchspecific substrate recognition for this family of enzymes. The resulting models also highlight the essential roles of steric restrictions for glycan cleavage and maturation of N-linked glycans, a fundamental process for glycoprotein biosynthesis in the eukaryotic secretory pathway.
Results
Structure and Ion Coordination of the ERManI T688A Mutant. Substrate interactions with the GH47 α-mannosidases are stabilized in part by the direct association of the α1,2-linked mannose glycone residue with the enzyme-bound Ca 2+ ion in the −1 subsite. Chelation of the Ca 2+ ion leads to enzyme inactivation, whereas its replacement with alternative cations can lead to enzyme inhibition (9, 22) . Mutation of the Ca 2+ -coordinating Thr residue (T688A for ERManI) reduced catalysis but also increased substrate-binding affinity, whereas the Ca 2+ -binding affinity was essentially unchanged (21) . Because the T688A mutant retains some catalytic activity toward α-mannoside substrates, we determined the crystal structure of the T688A mutant in complex with an uncleavable thiodisaccharide substrate analog (Table S1 ). The ERManI (T688A)-thiodisaccharide complex was highly similar in structure to the wild-type ERManI-thiodisaccharide complex [rmsd 0. versus Protein Data Bank (PDB) ID code 1X9D, hereafter "1X9D"] (14) with the major structural differences resulting from an altered glycone conformation and changes in Ca 2+ coordination (Fig. S1 ). The glycone residue of the thiodisaccharide assumed a 1 C 4 chair conformation rather than the 3 S 1 skew boat found in the prior 1X9D structure (Fig. S1) (14) . In addition, the Ca 2+ ion was seven-coordinate for the T688A mutant rather than eight-coordinate for the wild-type enzyme (Fig. S1 ). The positions of the ligand for the substrate analog, the carbonyl oxygen of A688, and three of the coordinating water molecules (W1, W2, and W3) were similar to their positions in the wild-type ERManIthiodisaccharide complex (Fig. S1) . No additional ligands replaced the missing T688 side-chain hydroxyl group, but the fourth water ligand (W4) in the T668A mutant complex was repositioned significantly closer to the missing Thr side chain (Fig. S1 A, C, and  G) . Thus, the structure indicates that the removal of one point of Ca 2+ coordination in the T688A mutant likely accounts for the reduced catalytic turnover by the mutant enzyme and demonstrates that ion coordination plays a direct and essential role in catalysis. (Table S2 ) with a primary effect on k cat but not K m . In contrast, no enzyme activity was detected in the presence of La
3+
. A similar inactivation of GMIA was seen following La 3+ substitution. Substrate-binding affinity also was tested by surface plasmon resonance (SPR) using both wild-type ERManI and a mutant with reduced catalytic activity (E330Q) (21) in the presence of the respective cations (Table S3 ). These studies indicated that substrate-binding affinity was comparable in the presence of Ca 2+ , Sr 2+ , or Ba 2+ but was significantly reduced in the presence of Mg 2+ (Table S3 ) Surprisingly, high glycan-binding affinity was observed in the presence of La 3+ , indicating that, despite complete enzyme inactivation by the cation, the enzyme retained high substrate-binding affinity and might provide access to structural studies on enzyme-substrate complexes.
Structures of Substrate Complexes for GMIA and ERManI. Bound Ca 2+ in both ERManI and GMIA was exchanged for La
, and substrate interactions were examined for each enzyme by cocrystallization with Man 9 GlcNAc 2 substrate analogs. The resulting enzyme-La 3+ -glycan complex structures for both ERManI and GMIA were solved by molecular replacement at 1.65-Å and 1.77-Å resolution, respectively. The structure of the ERManILa 3+ -glycan complex was highly similar to the prior ERManICa 2+ -thiodisaccharide complex (rms 0.121 Å versus 1X9D) (14) . For the GMIA-La 3+ -glycan complex, each of the two chains in the asymmetric unit were highly similar (rms 0.07 Å for chain A versus chain B), and the overall protein folds were highly similar to the structure of the GMIA-Ca 2+ -glycan complex (rms of 0.30 Å for both chains A and B versus PDB ID code 1NXC, hereafter "1NXC") (20) , with the predominant structural changes for both enzymes being found in ion coordination and for the residues within the glycan-binding clefts.
Both the ERManI-and GMIA-La 3+ -Man 9 GlcNAc 2 complexes contained clear densities in the active-site clefts representing bound glycan structures (Fig. 2) . However, the orientations of the glycans were quite different. For both enzymes, the modeled structures unambiguously identified eight of nine mannose residues and the core N-acetylglucosamine (GlcNAc) residue (NAG2) (Figs. 2 and 3 ). Only the M11 residue was missing from the refined electron density for ERManI, and this residue would have been positioned facing the solvent in the structural model ( Figs. 2 and 3) . Similarly, residue M9 was missing in the GMIA structure and also would have faced into the solvent. Both complexes were also missing the first GlcNAc residue (NAG1) and the pyridylamine tag on the substrate analogs, which also face into the solvent. For ERManI, the glycan was positioned with the M10 residue (branch B) in the −1 subsite as expected for an enzyme-substrate complex, and the remainder of the glycan structure formed a broad, flattened collection of interactions across the glycan-binding cleft extending from the −1 subsite toward the solvent at the opening of the cleft (Figs. 3 and 4 and Table S4 ). For GMIA, the glycan was positioned with the terminal residue of branch A (M11) extending into the −1 subsite. The other glycan branches were considerably less flattened across the glycan-binding cleft than the equivalent branches in the corresponding ERManI-glycan complex and instead formed a more compact arrangement with fewer direct interactions with residues in the GMIA glycan-binding cleft (Figs. 3 and 4 and Table S4 ).
Ion Coordination and Sugar Conformations in the Active Sites. We hypothesized that replacing Ca 2+ with La 3+ might result in altered ion coordination and account for the loss of enzyme activity. Comparison of the ERManI-La 3+ -Man 9 GlcNAc 2 complex with the ERManI-Ca 2+ -thiodisaccharide complex (14) indicated that the substrate glycone and the T688 residue were coordinated to the cation in identical positions ( Fig. S1 D and F) . On the opposite side of the La 3+ ion, five water molecules were coordinated rather than the four found in the enzyme-Ca 2+ complex, resulting in a La 3+ -centered ninefold trigonal prismatic (square-faced tricapped) coordination (Fig. S1 D, E, I , and J). Three waters in the enzyme-La 3+ complex (W1-3 La ) were located at approximately equivalent positions relative to the enzyme-Ca 2+ complex (W1-3 Ca ) (Fig. S1 ). However, both W4 La and W5 La were in positions distinct from W4 Ca (Fig. S1F) . The ERManI-and GMIA-La 3+ -Man 9 GlcNAc 2 complexes were virtually superimposable in both their −1 and +1 subsites, indicating that La 3+ coordination is the same for both enzymes (Fig. S1 D and E) . Thus, the only differences in ion coordination between the enzyme-La 3+ structures and the corresponding enzyme-Ca 2+ complexes were the altered positions of one water molecule, the appearance of one additional coordinated water molecule in the La 3+ complex, and the increased charge of the bound ion.
Prior structures of inhibitors or substrate analogs that occupy the GH47 enzyme −1 subsites as Ca 2+ complexes revealed dis-
S 1 sugar conformations (14, (16) (17) (18) (19) ) that mimic intermediates in the proposed conformational itinerary during catalysis (14, 19) . In the ERManI-and GMIA-La 3+ -substrate complexes the mannose residue in the −1 subsite assumed a 1 C 4 chair conformation and also retained normal glycosidic bond lengths to the +1 mannose residue (Fig. S1 M and N) . Thus, the two structures represent interactions between the enzymes and uncleaved substrates that presumably resemble Michaelis complexes in which the glycone conformations are approaching the transition states for glycoside bond hydrolysis.
Glycan Interactions in the Enzyme Active-Site Clefts. Prior studies on yeast ERManI revealed a complex with a Man 5 GlcNAc 2 glycan product in the enzyme-binding cleft (≥+1 subsites) (PDB ID code 1DL2, hereafter "1DL2") (10). The Man 5 GlcNAc 2 ligand was devoid of α1,2-linked mannose residues, and the −1 subsite was unoccupied, but residue M7 from branch B was found in the enzyme +1 subsite (Fig. 3B) 5 GlcNAc residues in the respective active-site clefts despite the two glycans being quite different in size and yeast and human ERManI being only 42% identical in primary sequence (Fig. 3E) . Interactions with the core Man 5 GlcNAc glycan residues also were quite similar ( Fig. 4 and Table S4), particularly for glycan residues M7, M4, and M3. Differences in H-bonding were found for residues M6, M5, and NAG2, and hydrophobic stacking interactions with NAG2 were found for the human enzyme (with W389) but not for the yeast enzyme.
The original crystal structure of mouse GMIA also represented an enzyme-product complex with the equivalent of Man 5 GlcNAc 2 occupying the ≥+1 subsites and the −1 subsite unoccupied (1NXC) (20) . Binding of the Man 5 GlcNAc 2 glycan in the GMIA cleft led to the insertion of residue M6 from branch C into the +1 subsite (Fig. 3D) . In contrast, the present GMIALa 3+ -Man 9 GlcNAc 2 complex reflected the insertion of residue M11 from branch A into the −1 subsite, and residue M8 occupied the +1 subsite (Figs. 3C and 4B). As expected from the distinct glycan branches occupying the −1/+1 subsites for the two GMIA-glycan complexes, each complex had different interactions between the glycan and residues in the binding cleft ( Fig.  4B and Table S4 ). Interacting residues in the +1 subsite were identical, but all other interactions in the >+1 subsites for the GMIA-La 3+ -Man 9 GlcNAc 2 and GMIA-Ca 2+ -Man 5 GlcNAc 2 complexes were entirely different. For both glycan complexes the interactions extended all the way from the +1 subsite to the core Man-β1,4-NAG linkage at the cleft opening (Fig. 4 and Table S4 ). These interactions combine both direct and indirect (through bridging water molecules) H-bonding and hydrophobic stacking to either M3 (with W339 for the Man 9 GlcNAc 2 complex) (Fig. 4 ) or NAG2 (with W341 for the Man 5 GlcNAc 2 complex). Interestingly, W341 is rotated by ∼180°in the Man 9 GlcNAc 2 complex to avoid a steric clash with NAG2, whereas an alternative hydrophobic anchoring interaction with W339 was used with the C5-C6 region of the M3 residue (Fig. S3) . Overall, there were fewer direct H-bonding interactions to fewer glycan residues in the GMIALa 3+ -Man 9 GlcNAc 2 complex (14 total H-bonds to five glycan residues) than in the ERManI-La 3+ -Man 9 GlcNAc 2 complex (21 total H-bonds to nine glycan residues) (Table S4 ).
Kinetic Analysis of Wild-Type and Mutant Forms of ERManI and GMIA.
The differences in substrate specificity between ERManI and GMIA were seen most readily through in vitro time-course studies of Man 9 GlcNAc 2 substrate cleavage. ERManI readily converted Man 9 GlcNAc 2 to Man8B by removal of the M10 residue, but further digestion to Man 7-5 GlcNAc 2 occurred comparatively slowly ( Fig. 1 and Fig. S4 ). In contrast, GMIA readily cleaved Man 9-GlcNAc 2 to Man 6 GlcNAc 2 with transient accumulations of each intermediate structure (Man 8 GlcNAc 2 -Man 6 GlcNAc 2 ) in progression through the time course and slow cleavage to Man 5 GlcNAc 2 ( Fig. 1 and Fig. S4 ). To test the roles of the individual amino acids in the substrate-binding cleft in substrate cleavage, residues in ERManI were mutagenized to the equivalently positioned residues in GMIA, and time-course studies of substrate cleavage were performed.
Mutagenesis of several of the individual glycan-interacting residues in the ERManI-La 3+ -Man 9 GlcNAc 2 complex (Fig. 4 and Table S4 ) resulted in minor alterations in glycan cleavage including, in some cases, low levels of cleavage beyond Man 8 GlcNAc 2 (i.e., in N327S, S375A, D523G, D376L, A590N, and D591E) (Fig. S4) . All the latter mutants showed some degree of compromised catalytic activity (Table S5) .
In contrast, mutagenesis of Arg461 in ERManI, which interacts with residues M3, M7, and NAG2 in the ERManI-La 3+ -Man 9 GlcNAc 2 complex (Fig. 4 and Table S4 ), to the topologically equivalent Leu residue in GMIA resulted in a hybrid activity -glycan complex, the glycan structure is referred to as a "GMIA-Ca 2+ -Man 5 GlcNAc 2 " complex throughout this paper. In the lower diagrams in C and D, two additional sets of glycan structural representations are shown with a 90°rotation to illustrate the differences in glycan structural positions. (E) A structural overlay of the Man 9 GlcNAc 2 glycan from human ERManI in A and the Man 5 GlcNAc 2 glycan from yeast ERManI in B demonstrating a close structural superimposition for the two glycan structures. (F) A structural overlay of the Man 9 GlcNAc 2 glycan from GMIA in C and the Man 6 GlcNAc 2 glycan from GMIA in D demonstrating that the glycan structural conformations in these two complexes are quite different and also are quite different from the corresponding ERManI-glycan complexes. Branch designations for the individual arms of the Man 9 GlcNAc 2 -glycan structure, based on the nomenclature shown in Fig. 1, are (Fig. S4) . However, the efficiency of cleavage and glycan-binding affinity were significantly reduced (Tables  S3 and S5 ). In contrast, the opposite mutation in GMIA (L413R) resulted in an enzyme that still resembled GMIA (Fig. S4) , albeit with significantly reduced catalytic activity (Table S5) .
At the core of the bound glycan for both the ERManI-La 3+ -Man 9 GlcNAc 2 and GMIA-Ca 2+ -Man 5 GlcNAc 2 complexes (20) a Trp residue (W389 in ERManI and W341 in GMIA) provides hydrophobic stacking interactions with NAG2 in the substrate analog. An ERManI W389A mutant exhibited broader hybrid specificity for cleavage beyond Man 8 GlcNAc 2 (Fig. S4) to produce a mixture of Man 6 GlcNAc 2 and Man 5 GlcNAc 2 . This altered specificity presumably results from a reduction in anchoring interactions at the core of the glycan structure and more flexible glycan interactions within the cleft. Further analysis revealed reduced catalytic efficiency and glycan-binding affinity for the W389A mutant (Tables S3 and S5). In addition, the isomer structure generated as a transient cleavage intermediate resembled ERManI specificity rather than the Man8A product that is generated by GMIA (Fig. S5) .
Additional efforts to swap the specificities of ERManI and GMIA were pursued by the mutagenic conversion of the full collection of glycan-interacting residues in ERManI to the equivalent residues in GMIA (N327S/S375A/D376L/R461L/ D523G/A590N/D591E). The combinatorial mutant enzyme resembled wild-type GMIA in glycan cleavage (Fig. S4 ) with broadened specificity for cleavage beyond Man 8 GlcNAc 2 and accumulation of Man 6 GlcNAc 2 before slowly generating Man 5 GlcNAc 2 . However, the catalytic efficiency and glycan-binding affinity of the mutant was reduced considerably compared with wild-type GMIA (Tables S3 and S5) , and analysis of the Man 8 GlcNAc 2 structure demonstrated a mixture of Man8B and Man8A isomers (60%:40%, Fig. S5 ). These results indicate that the mutant gained a broader substrate specificity that more closely resembled GMIA but still retained an initial glycan-cleavage specificity reflecting a hybrid between ERManI and GMIA.
An equivalent combinatorial mutant of GMIA was also generated in which the full collection of glycan-interacting residues in GMIA was swapped with the equivalent residues from ERManI (S279N/A327S/L328D/P340R/L413R/G474D/N540A/ E541D). This latter combinatorial mutant did not resemble either ERManI or GMIA in its cleavage profile (Fig. S4) . Compared with wild-type GMIA, the combinatorial mutant exhibited a slower cleavage of Man 8 GlcNAc 2 (Table S5) , slower progression to Man 6 GlcNAc 2 , and more rapid conversion to Man 5-GlcNAc 2 (Fig. S4) . Analysis of the Man 8 GlcNAc 2 isomer intermediates demonstrated a mixture of all three Man 8 GlcNAc 2 isomers (Fig. S5 ) compared with GMIA (90% Man8A) or ERManI (100% Man8B), suggesting a promiscuous specificity unlike either of the wild-type enzymes.
Discussion
The present findings provide an unprecedented level of insight into the mechanism of α1,2-mannosidase reactions, which was made possible by the parallel comparison of two distinct enzymes, trapping of Michaelis complexes by a metal substitution, and mutagenesis to direct the specificity of one enzyme toward that of the other. The studies also advance our understanding of the bioinorganic chemistry of cations in enzymatic catalysis, the conformational itineraries in glycoside bond hydrolysis, the evolution of active-site structures that provide novel enzyme specificities Monosaccharides in the glycan structures are labeled in purple using the nomenclature described in Fig. 1 . Amino acid residues labeled in red are residues that were subjected to mutagenesis and time-course studies for glycan cleavage (Fig. S4 and Table S5 ). Other amino acid residues in the active-site cleft are labeled in black.
within the constraints of a common catalytic mechanism, and the contributions of steric factors to control the efficiency of metabolic processing during mammalian glycan maturation. Key findings and their implications are summarized below.
Glycan Distortion Precedes Hydrolysis. Most glycosidases use a pair of amino acid carboxylate side chains in acid/base chemistry or as transient covalent intermediates to achieve bond hydrolysis. Rarely are cations used for either substrate interactions or catalysis. However, the cleavage of α-mannosidic linkages presents an unusual enzymatic challenge because the axially positioned hydroxyl group at C2 sterically hinders nucleophilic attack at the C1 position of the glycone residue. Exo-α-mannosidases generally alleviate this steric barrier by distorting the substrate from its ground state 4 C 1 chair conformation to reposition the C2 hydroxyl through coordination with an enzyme-bound divalent cation (Fig. 5B) (23) . Three families of exo-α-mannosidases (CAZy GH38, GH47, and GH92) (24) are unique among the glycoside hydrolases in their use of divalent cations for substrate binding and catalysis (10, 14, 23, 25) . Each enzyme family uses a distinct combination of divalent cation interactions, glycone distortion, transition state structures, and catalytic mechanisms. For the GH47 enzymes, a Ca 2+ ion is used both for substrate interactions and for glycone distortion into a proposed (50) in which Man residues (green spheres) and GlcNAc residues (blue cubes) are connected by glycosidic linkages (gray lines). Initial substrate interactions with a specific Man 9 GlcNAc 2 -Asn conformation in the ERManI glycan-binding cleft (step 1) result in the insertion of the terminal Manα1,2-Man disaccharide from the B branch into the −1/+1 catalytic subsites (enzymes are shown in A as gray surface representations). Residues that were not resolved in the respective enzyme-glycan complexes are shown in their anticipated positions in the structures (Man residues are shown as light green circles with dotted outlines and GlcNAc residues as light blue cubes with dotted outline). Following glycoside bond hydrolysis, the Man 8 GlcNAc 2 -Asn product and free Man residue must dissociate completely from the enzyme active site before conformational rearrangement and binding for the subsequent cleavage step. Conformational rearrangement leads to the insertion of branch A of the Man 8 GlcNAc 2 -Asn substrate in the GMIA glycan-binding cleft (step 2) with subsequent bond hydrolysis and dissociation of the Man 7 GlcNAc 2 -Asn product and the free Man residue. Similar conformational rearrangements lead to the binding of branch C of the Man 7 GlcNAc 2 -Asn substrate in step 3 and to the binding of branch A of the Man 6 GlcNAc 2 -Asn substrate to the GMIA glycan-binding cleft in step 4 (the structure of the bound complex is unknown). Each step in the cleavage series requires a different glycan structural conformation that is complementary to the geometry of the enzyme glycan-binding cleft. (B) The conformational distortion of the terminal mannose glycone residue upon binding to the active site and the enzymatic mechanism for all GH47 α-mannosidases. The dotted red box represents the proposed catalytic mechanism for bond hydrolysis by all GH47 α-mannosidases (including all ERManI and GMIA cleavage steps). Conformation distortion of the low free energy 4 C 1 ground state for the terminal α1,2-Man residue occurs as it enters the −1 subsite. Initial binding of the glycone in a 1 C 4 conformation is facilitated by hydrogen bonding, hydrophobic interactions (not shown), and coordination of the enzyme-bound Ca 2+ ion with the glycone residue C2 and C3 hydroxyls. A conformational least-motion twist at C1 and the ring oxygen atom leads to a transient 3,0 B/ 3 S 1 intermediate conformation followed by ring flattening to the 3 H 4 oxocarbenium ion transition state and release of the glycone in a 1 C 4 conformation. Deprotonation and attack of the glycosidic C1 by the hydroxide anion nucleophile (coordinated with the Ca 2+ ion as a pronucleophile) leads to a change in coordination number from 8 to 7 for the cation. Release of the β-Man product into solution results in a conformational shift back to the low free energy 4 C 1 ground state.
structure as the ring-flattened transition state (Fig. 5B) (14, 19) . Both GH47 and GH92 α-mannosidases also use a water pronucleophile that is directly coordinated to the enzyme-bound Ca 2+ ion during their inverting catalytic mechanisms (14, 23) . Because the water pronucleophile molecule also interacts with a catalytic Brønsted base (Glu in GH47 and Asp in GH92) to achieve deprotonation, it is anticipated that the resulting nucleophilic hydroxide anion will depart from the Ca 2+ ion coordination sphere during attack on the glycosidic C1. A consequence of this attack would be the transient change from an eight to seven coordinated Ca 2+ ion during catalysis (Fig. 5B) -binding sites in proteins (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) (36) (37) , although the mechanism by which La 3+ influences the enzyme activities of ion-bound complexes has not been studied systematically. Among the lanthanide family, La 3+ exhibits physical and chemical properties similar to Ca 2+ , including a similar ionic radius (1.30 and 1.26 Å, respectively, for eight coordinated metal ions) (38) , and acts as a hard Lewis acid that prefers to bind hard bases containing oxygen (39) . However, La 3+ is distinct in acting as a stronger Lewis acid than Ca 2+ , with a higher affinity toward oxygen-containing biological ligands, and has a 10-fold slower ligand exchange rate than Ca 2+ (40) . Our structural studies with ion substitution indicate that altered coordination geometry and electrostatics of the La 3+ complex directly impact catalytic efficiency. The conversion to a nine-coordinate geometry for the La 3+ -enzyme complex, combined with the stronger Lewis acid character and the tighter electrostatic interactions between the trivalent cation and the developing hydroxide anion nucleophile, led to a trapped Michaelis complex that was incapable of glycoside bond hydrolysis. Thus, the normal role of the enzyme-bound Ca 2+ ion in catalysis by the GH47 α-mannosidases arises from an eight-coordinate cation complex that presumably provides an optimal balance of coordination geometry, electrostatics for high-affinity substrate interactions, and the effective release of the forming hydroxide anion for nucleophilic attack on the glycoside bond with a subsequent transient transition to a seven-coordinate Ca 2+ ion configuration associated with the enzymatic product.
The Michaelis Complex Demonstrates the Glycone Conformational
Itinerary During Bond Hydrolysis. Rarely is it possible to trap intact, uncleaved natural substrates in glycoside hydrolase active sites as Michaelis complexes without making significant alterations to either the catalytic site residues or the substrate structure. Both enzyme-La 3+ -Man 9 GlcNAc 2 complexes represent intact enzyme-bound substrates with glycone distortion into a 1 C 4 chair conformation and normal glycosidic bond lengths. By contrast, prior studies on GH47 enzymes used glycone-mimicking inhibitors or poorly cleaved thiodisaccharide substrate analogs as surrogates for bound natural substrates. The thiodisaccharide complexes displayed glycone residues bound in 3 S 1 skew boat conformations (14, 19) which may have been induced by the longer C-S-C bond lengths (∼1.8 Å) (Fig. S1) . However, the presence of a 1 C 4 chair conformation for the seven-coordinate ERManI(T688A)-Ca 2+ -thiodisaccharide complex indicates that the longer bond lengths also can be accommodated in a 1 C 4 chair conformation for the latter complex. These data demonstrate that ion coordination can influence the conformation of the bound glycone residue in the respective structures. By comparison, several inhibitors bound to GH47 enzymes in 1 C 4 chair conformations (16, 17, 19) , whereas mannoimidazole bound in the proposed 3 H 4 half-chair transition state conformation (19 (Fig. 5B) . Thus, the trapped uncleaved substrate complexes provide a direct structural snapshot of a presumed Michaelis complex during glycoside bond hydrolysis without requiring alterations in catalytic residues or the substrate structure.
Cleavage Specificity Depends on Global Substrate Contacts to Orient the Scissile Bond. Comparison of the GH47 enzyme-glycan complexes (Figs. 3 and 5A ) shows how two highly related enzyme structures can bind to the same substrates via completely distinct glycan termini using different binding modes and unique glycan substrate conformations. For the ERManI-La 3+ -Man 9 GlcNAc 2 complex, it is the geometry of the core Man 5 GlcNAc 2 glycan residues and their interactions with the active-site cleft that specifies the selective recognition and cleavage of the substrate branch B rather than contributions from the extended terminal α1,2-linked mannose residues (Fig. 5B) . Presumably the other glycan branch termini are not compatible with the geometry of the ERManI glycan-binding cleft.
In contrast, GMIA may appear to be more promiscuous in its cleavage of three mannose residues from Man 9 GlcNAc 2 (branches A and C) as compared with the single cleavage of residue M10 (branch B) by ERManI. However, the GMIA cleavage series is surprisingly restricted and sequential, with initial cleavage of residue M11 (branch A) followed by residue M9 (branch C) and residue M8 (branch A) and considerably slower cleavage of residue M10 (branch B) (Fig. 5A) . In this cleavage series the GMIA-La 3+ -Man 9 GlcNAc 2 complex would reflect the first cleavage step with the insertion of M11 (branch A) into the −1 subsite. The mode of substrate binding in this complex and the glycan conformation are entirely different from those in the ERManI-La 3+ -Man 9 GlcNAc 2 complex except for the identical recognition of the terminal Man-α1,2-Man disaccharide in the −1/+1 subsites. By comparison, the GMIACa 2+ -Man 5 GlcNAc 2 product complex has an insertion of branch C into the +1 subsite and does not reflect the enzymatic product for either the initial or final cleavage of Man 9 GlcNAc 2 by GMIA. Instead, insertion of residue M6 from branch C into the +1 subsite represents the product of the second step in the GMIA cleavage hierarchy (Fig. 5A) . The clear differences in glycan geometry and interacting residues between the two GMIA-glycan substrate and -product complexes, with virtually no overlap in glycan positions other than the residue in the +1 subsite, indicates that the patterns of binding interactions for the sequential cleavage reactions by GMIA change substantially at each stage of glycan hydrolysis (Fig.  5A) . Because the glycan-binding cleft for GMIA is considerably more constricted than that of ERManI (20) , only a restricted set of glycan geometries is available for insertion into the active site. These restraints in cleft geometry, along with the flexible collection of indirect H-bonding substrate interactions in the glycanbinding cleft, allow GMIA to bind unique glycan branch termini for each step in the selective, ordered, and sequential series of glycan-cleavage events. Each cleavage event is presumably followed by the complete dissociation of the glycan product, exit of the cleaved glycone residue from the buried −1 subsite, and reorientation of the resulting glycan structure, before binding as the substrate for the next cleavage step (Fig. 5A) .
The collection of GH47 enzyme-glycan complex structures as substrate or product complexes now reveals a series of snapshots for three distinct cleavage events (Fig. 5A) . The similarities in overall protein fold for all the GH47 α-mannosidases suggest that these enzymes use a common structural scaffold and catalytic core −1/+1 subsites, but each enzyme employs a distinct cleft geometry to achieve branch-specific glycan recognition. Efforts to swap the specificities of ERManI and GMIA by interchanging individual cleft residues led to limited success, suggesting that substrate recognition is more complicated than the contributions of individual residues. The combinatorial exchange of all glycan-interacting residues in ERManI for equivalent residues from GMIA resulted in hybrid activity that more closely resembled GMIA, including a partial conversion in the initial branch cleavage by the mutant enzyme. However, the inverse combinatorial mutant (a multisite GMIA mutant harboring equivalent ERManI residues) produced an enzyme with a specificity unlike either parent enzyme. These data suggest that it is the broader collection of residues within the overall cleft topology that contributes to efficient and selective glycan cleavage.
Finally, both GH47 α-mannosidases engage their substrates by remarkably large contact interfaces for protein-sugar recognition, which is important for presenting the correct glycan termini to the respective enzyme active sites. A hallmark of the bound substrate complexes for both enzymes is hydrophobic stacking interactions between Trp residues and the glycan core (either NAG2 or M3 residues) that anchors the base of the glycan structure to the enzyme cleft. Mutation of this residue in ERManI (W389A) allowed a broadened cleavage to Man 6-5 GlcNAc 2 structures partially resembling a GMIA-like specificity that presumably results from altered interactions within the glycanbinding cleft. Thus, alternative hydrophobic interactions are used at multiple cleavage steps and combine with a broad H-bonding network to establish an unusual paradigm for protein-glycan interactions that extend across the entire glycan structure.
Implications for Processing of Oligomannose Glycans in the Secretory
Pathway. The extended interactions between the GH47 α-mannosidases and the full glycan substrate structures have significant implications for glycan processing in the secretory pathway. The potential for local protein-specific steric barriers to impair glycan cleavage and maturation has been described previously (41) (42) (43) (44) (45) , but the structural basis for these observations has remained obscure. Recent studies demonstrated that glycan interactions with an adjacent protein domain in a soluble Pdi1 reporter glycoprotein reduced α1,2-mannose trimming efficiency (45) . Removal of the respective domain rescued glycan trimming and maturation in this model system. In HIV gp120, a regional highdensity clustering of glycosylation sites results in the formation of an under-processed "mannose patch" comprising a network of interlocking oligomannose structures that protects the virus from antibody-mediated neutralization (46, 47) . In contrast, glycan structures outside the mannose patch were converted to complex-type structures (46) , indicating that normal glycan maturation would occur if there were adequate steric access to the glycan substrates. Thus, the high-density glycan clustering within the mannose patch presumably impaired steric access to cleavage by the GH47 α-mannosidases. Finally, the impact of proteinglycan interactions on glycan maturation was examined as a part of a larger study on residues that flank glycosylation site acceptor sequons (48) . Aromatic residues at the n-2 positions relative to glycosylation sites on the polypeptide backbone resulted in increased glycan occupancy but also reduced the efficiency of glycan trimming. The authors suggested that the presence of the n-2 aromatic residue resulted in the formation of a reverse turn as a result of hydrophobic stacking between the aromatic residue and the nonpolar face of the adjoining glycan core GlcNAc residue (49) . These interactions presumably would compete with steric access for binding to the cleft in the GH47 α-mannosidases and would lead to less efficient mannose cleavage. Thus, complete steric access to the core glycan residues contributes to the efficiency of glycan cleavage by the GH47 α-mannosidases in vivo and influences the conversion to complex-type structures at individual glycan sites on cell-surface and secreted glycoproteins. By extension, these steric issues also would impact glycan maturation on many secreted recombinant products including commercially important biomolecules such as glycosylated therapeutics. Similar issues of steric access to substrate structures presumably also occur for many other glycan-processing enzymes in the secretory pathway and are likely contributors to the diversity and heterogeneity of glycan structures in eukaryotic cells.
Materials and Methods
Detailed discussions of the materials and methods used in this study are provided in SI Materials and Methods.
Protein Expression and Purification. The catalytic domains of wild-type or sitedirected mutants of human ERManI and mouse GMIA were expressed in Pichia pastoris and purified as described SI Materials and Methods.
Generation of Mutants. Site-directed mutagenesis was performed using the QuikChange mutagenesis kit in the respective pPICZα or pHIL-S1 expression vectors as described in SI Materials and Methods.
Preparation of the Man 9 GlcNAc 2 -PA Substrate Analog. Man 9 GlcNAc 2 was isolated from soybean agglutinin (SBA) and was reductively aminated with 2-amino pyridine (PA) as described in SI Materials and Methods.
Crystallization and X-Ray Diffraction. Crystals of wild-type and mutant forms of GMIA and ERManI were generated from purified enzyme preparations and premixed with Man 9 GlcNAc 2 -PA or thiodisaccharide substrate analogs as described in SI Materials and Methods. Crystals were grown using hangingdrop vapor-diffusion methods, and diffraction data were collected at the Southeast Regional Collaborative Team/Advanced Photon Source (SER-CAT/ APS) at Argonne National Laboratory and processed as described in SI Materials and Methods. The structures were solved by molecular replacement as described in SI Materials and Methods.
Enzyme Assays and Time Course of Glycan Digestion. Enzyme assays were performed using Man 9 GlcNAc 2 -PA as substrate, and enzymatic products were resolved at individual time points by NH 2 -HPLC as described in SI Materials and Methods.
Binding Studies by SPR. SPR analyses were conducted using a Biacore 3000 apparatus (Biacore AB) with recombinant enzymes immobilized on the CM5 SPR chip surface and Man 9 GlcNAc 2 -PA as the analyte as described in SI Materials and Methods.
